Autosomal dominant mental retardation;Retraso mental autosómico dominante

Revista de Neurologia

Volumn 42, Issue SUPPL.1, 2006, Pages

  Sánchez Díaz, Aurora ^a   Morales Peydro C ^a   Madrigal Bajo, I ^a  

^a HOSPITAL CLÍNIC   (Spain)

Author keywords

Mental retardation; Neurofibromatosis 1; Steinert's myotonic dystrophy; Tuberous sclerosis

Indexed keywords

MYOTONIC DYSTROPHY PROTEIN KINASE; TUBERIN;

AUTOSOMAL DOMINANT DISORDER; AUTOSOMAL DOMINANT INHERITANCE; CELL MEMBRANE; CELL NUCLEUS; CLINICAL FEATURE; DISEASE TRANSMISSION; GENE MUTATION; HUMAN; LEARNING; MEMORY; MENTAL DEFICIENCY; MONOGENIC DISORDER; MYOTONIC DYSTROPHY; NERVE CELL PLASTICITY; NEUROFIBROMATOSIS; REVIEW; SIGNAL TRANSDUCTION; TUBEROUS SCLEROSIS;

GENES, DOMINANT; HUMANS; MENTAL RETARDATION; MYOTONIC DYSTROPHY; NEUROFIBROMATOSIS 1; TUBEROUS SCLEROSIS;

EID: 34548771747     PISSN: 02100010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (48)

1. Curry CJ, Estevenson RE, Aughton D, Byrne J, Carey JC, Cassidy S, et al. Evaluation of mental retardation: recommendations of a consensus conference. Am J Med Genet 1997; 72: 468-77.
2. Van Karnebeek CDM, Jansweijer MCE, Leenders AGE, Offringa M, Hennekam R. Diagnostic investigation in individuals with mental retardation: a systematic literature review of their usefulness. Eur J Hum Genet 2005; 13: 6-25.
3. Rehder H, Fritz B. Genetic causes of mental retardation. Wien Med Wochenschr 2005; 155: 248-67.
4. Johnston MV, Alemi L, Harum KH. Learning, memory, and transcription factors. Pediatrics Res 2003; 53: 369-74.
5. Johnston MV, Nishimura A, Harum K, Pekar J, Blue ME. Sculpting the developing brain. Adv Pediatr 2001; 48: 1-38.
6. Weeber EJ, Leverson JM, Sweatt JD. Genes and proteins involved in cognition. Mol Genet Hum Cogn 2002; 2: 376-91.
7. Ozonoff S. Cognitive impairment in neurofibromatosis type 1. Am J Med Genet 1999; 89: 45-52.
8. Huson SM, Compston DA, Clark P, Harper PS. A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet 1989; 26: 704-11.
9. Huson SM, Hughes RAC. The neurofibromatoses: a pathogenetic and clinical overview. London: Chapman & Hall Medical; 1994.
10. Huson SM, Harper PS, Compston DA. Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain 1988; 111: 1355-81.
11. Riccarddi VM. Neurofibromatosis: phenotype, natural history and pathogenesis. Baltimore: Johns Hopkins University Press; 1992.
12. Viskochil D, Carey JC. Nosological considerations of the neurofibromatoses. J Dermatol 1992; 19: 873-80.
13. Moore BD, Slopis JM, Schomer D, Jackson EF, Levy BM. Neuropsychological significance of areas of high signal intensity on brain MRIs of children with neurofibromatosis. Neurology 1996; 46: 1660-8.
14. Mulvihill JJ. Neurofibromatosis. A genetic epidemiologist's point of view. Ann N Y Acad Sci 1986; 486: 38-44.
15. Cawthon RM, Weiss R, Xu GF, Viskochil D, Culver M, Stevens J, et al. A major segment of the neurofibromatosis type 1 gene: cDNA sequence, genomic structure, and point mutations. Cell 1990; 62: 193-201.
16. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, et al. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus. Cell 1990; 62: 187-92.
17. Wallace MR, Andersen LB, Saulino AM, Gregory PE, Glover TW, Collins FS. A de novo Alu insertion results in neurofibromatosis type 1. Nature 1991; 353: 864-6.
18. Li Y, O'Connel P, Breidenbach HH, Cawthon R, Stevens J, Xu G, et al. Genomic organization of the neurofibromatosis 1 gene (NF1). Genomics 1995; 25: 9-18.
19. Stephens K, Kayes L, Riccardi VM, Rising M, Sybert VP, Pagon RA. Preferential mutation of the neurofibromatosis type 1 gene in paternally derived chromosomes. Hum Genet 1992; 88: 279-82.
20. Lázaro C, Gaona A, Ainsworth P, Tenconi R, Vidaud D, Kruyer H, et al. Sex differences in mutational rate and mutational mechanism in the NF1 gene in neurofibromatosis type 1 patients. Hum Genet 1996; 98: 696-9.
21. Upadhyaya M, Ruggieri M, Maynard J, Osborn M, Hartog C, Mudd S, et al. Gross deletions of the neurofibromatosis type 1 (NF1) gene are predominantly of maternal origin and commonly associated with a learning disability, dismorphic features and developmental delay. Hum Genet 1998; 102: 591-7.
22. Drost JB, Lee WR. Biological Basis of germline mutation: comparisons of spontaneous germline mutation rates among Drosophila, mouse and human. Environ Mol Mutagen 2000; 25 (Suppl 26): 48-64.
23. Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, et al. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996; 380: 152-254.
24. Dorschner MO, Sybert VP, Weaver M, Pletcher BA, Stephens K. NF1 microdeletion breakpoints are clustered at flanking repetitive sequences. Hum Mol Genet 2000; 9: 35-46.
25. Andersen LB, Ballester R, Marchuk DA, Chang E, Gutmann DH, Saulino AM, et al. A conserved alternative splice in the von Recklinghausen neurofibromatosis (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-activation protein activity. Mol Cell Biol 1993; 13: 487-95.
26. Costa RM, Silva AJ. Molecular and cellular mechanisms underlying the cognitive deficits associated with neurofibromatosis 1. J Child Neurol 2002; 17: 622-6.
27. Sampson JR. TSC1 and TSC2: genes that are mutated in the human genetic disorder tuberous sclerosis. Bioch Soc Transac 2003; 31: 592-6.
28. Bernstein J. Renal cystic disease in tuberous sclerosis complex. Pediatr Nephrol 1993; 7: 490-5.
29. Moss J, Ávila NA, Barnes PM, Litzenberger RA, Betchle J, Brooks PG, et al. Prevalence and clinical characteristics of lymphangioleiomyomatosis (LAM) in patients with tuberous sclerosis complex. Am J Respir Crit Care Med 2001; 163: 669-71.
30. Fryer AE, Chalmers A, Connor JM, Fraser I, Povey S, Yates AD, et al. Evidence that the gene for tuberous sclerosis is on chromosome 9. Lancet 1987; 1: 659-61.
31. Kandt RS, Haines JL, Smith M, Northrup H, Gardner RJM, Short MP, et al. Linkage of an important gene locus for tuberous sclerosis to a chromosome 16 marker for polycystic kidney disease. Nat Genet 1992; 2: 37-41.
32. Van Slegtenhorst M, De Hoogt R, Hermans C, Nellist M, Janssen B, Verhoef S, et al. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997; 77: 805-8.
33. Cheadle JP, Reeve MP, Sampson JR, Kwiatkowski DJ. Molecular genetic advances in tuberous sclerosis. Hum Genet 2000; 107: 97-114.
34. Niida Y, Lawrence-Smith M, Banwell A, Hammer E, Lewis J, Beauchamp R, et al. Analysis of both TSC1 and TSC2 for germline mutations in 126 unrelated patients with tuberous sclerosis. Hum Mutat 1999; 14: 412-22.
35. Sampson JR, Maheshwar MM, Aspinwall R, Thompson P, Cheadle JP, Ravine D, et al. Renal cystic disease in tuberous sclerosis: role of the polycystic kidney disease 1 gene. Am J Hum Genet 1997; 61: 843-51.
36. Rose VM, Au KS, Pollom G, Roach ES, Prashner HR, Northrup H. Germ-line mosaicism in tuberous sclerosis: how common? Am J Hum Genet 1999; 95: 986-92.
37. Carbonara C, Longa L, Grosso E, Mazzucco G, Borrone C, Garre ML, et al. Apparent preferential loss of heterozygosity at TSC2 over TSC1 chromosomal regions in tuberous sclerosis hamartomas. Genes Chromosom Cancer 1996; 15: 18-25.
38. Olsson PG, Schofield JN, Edwards YH, Frischauf AM. Expression and differential splicing of the mouse Tsc2 homolog. Mamm Genome 1996; 7: 212-5.
39. Nellist M, Van Slegtenhorst MA, Goedbloed M, Van den Ouweland AMW, Halley DJ, Van der Sluijs P. Characterization of the cytosolic tuberin-hamartin complex: tuberin is a cytosolic chaperone for hamartin. J Biol Chem 1999; 274: 35647-52.
40. Meola G. Clinical and genetic heterogeneity in myotonic dystrophies. Muscle Nerve 2000; 23: 89-1799.
41. Brook JD, McCurrach ME, Harley HG, Buckber AJ, Church D, Aburatani H, et al. Molecular basis of myotonic dystrophy: expansion of trinucleotide (CTG) repeat at the 3′ end of a transcription encoding a protein kinase family member. Cell 1992; 68: 799-808.
42. Harley HG, Rundle SA, MacMillan JC, Myring J, Brook JD, Crow S, et al. Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet 1993; 52: 1164-74.
43. Hamshere MG, Harley H, Harper P, Brook JD, Brookfield JF. Myotonic dystrophy: the correlation of (CTG) repeat length in leucocytes with age at onset is significant only for patients with small expansions. J Med Genet 1999; 36: 59-61.
44. Monckton DG, Wong LJ, Ashizawa T, Caskey CT. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic distrophy males: small pool PCR. Hum Mol Genet 1995; 4: 1-8.
45. Barceló JM, Mahadevan MS, Tsilfidis C, Mackenzie AE, Korneluk RG. Intergenerational stability of the myotonic dystrophy protomutation. Hum Mol Genet 1993; 2: 705-9.
46. Ashizawa T, Dubel JR, Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology 1993; 43: 2674-8.
47. Meola G, Sansone V, Perani D, Colleluori A, Cappa S, Cotelli M, et al. Reduced cerebral blood flow and impaired visual-spatial function in proximal myotonic myopathy. Neurology 1999; 53: 1042-50.
48. Groenen P, Wieringa B. Expanding complexity in myotonic dystrophy. Bioessays 1998; 20: 901-12.